Shamim S Ahmed

US Patent:

6436950, Aug 20, 2002

Filed:

Jun 16, 1999

Appl. No.:

09/334304

Inventors:

Raja G. Achari - Millington NJ
Shamim Ahmed - Central Islip NY
Charanjit R. Behl - Hauppauge NY
Jorge C. deMeireles - Syosset NY
Vincent D. Romeo - Massapequa Park NY
Anthony P. Sileno - Brookhaven Hamlet NY

Assignee:

Nastech Pharmaceutical Company, Inc. - Hauppauge NY

International Classification:

A61K 3144

US Classification:

514284

Abstract:

Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

US Patent:

6740660, May 25, 2004

Filed:

Jan 31, 2002

Appl. No.:

10/062021

Inventors:

Raja G. Achari - Millington NJ
Shamim Ahmed - Central Islip NY
Charanjit R. Behl - Hauppauge NY
Jorge C. deMeireles - Syosset NY
Vincent D. Romeo - late of Massapequa Park NY
Anthony P. Sileno - Brookhaven Hamlet NY

Assignee:

Nastech Pharmaceutical Company, Inc. - Bothell WA

International Classification:

A61K 3144

US Classification:

514284

Abstract:

Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

US Patent:

20020165249, Nov 7, 2002

Filed:

Jan 31, 2002

Appl. No.:

10/062020

Inventors:

Raja Achari - Millington NJ, US
Shamim Ahmed - Central Islip NY, US
Charanjit Behl - Hauppauge NY, US
Jorge deMeireles - Syosset NY, US
Vincent Romeo - Massapequa Park NY, US
Anthony Sileno - Brookhaven Hamlet NY, US

Assignee:

Nastech Pharmaceutical Company, Inc.

International Classification:

A61K031/4745

US Classification:

514/289000

Abstract:

Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

US Patent:

20020193397, Dec 19, 2002

Filed:

Jan 31, 2002

Appl. No.:

10/062290

Inventors:

Raja Achari - Millington NJ, US
Shamim Ahmed - Central Islip NY, US
Charanjit Behl - Hauppauge NY, US
Jorge deMeireles - Syosset NY, US
Vincent Romeo - Massapequa Park NY, US
Anthony Sileno - Brookhaven Hamlet NY, US

Assignee:

Nastech Pharmaceutical Company, Inc.

International Classification:

A61L009/04
A61K031/473

US Classification:

514/295000, 424/045000

Abstract:

Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

US Patent:

20040204441, Oct 14, 2004

Filed:

Apr 21, 2004

Appl. No.:

10/830251

Inventors:

Raja Achari - Millington NJ, US
Shamim Ahmed - Central Islip NY, US
Charanjit Behl - Hauppauge NY, US
Jorge deMeireles - Syosset NY, US
Vincent Romeo - Massapequa Park NY, US
Anthony Sileno - Brookhaven Hamlet NY, US

Assignee:

Nastech Pharmaceutical Company, Inc.

International Classification:

A61K031/4745

US Classification:

514/295000

Abstract:

Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

US Patent:

20040242624, Dec 2, 2004

Filed:

Apr 21, 2004

Appl. No.:

10/830250

Inventors:

Raja Achari - Millington NJ, US
Shamim Ahmed - Central Islip NY, US
Charanjit Behl - Hauppauge NY, US
Jorge deMeireles - Syosset NY, US
Vincent Romeo - Massapequa Park NY, US
Anthony Sileno - Brookhaven Hamlet NY, US

Assignee:

Nastech Pharmaceutical Company, Inc.

International Classification:

A61K031/473

US Classification:

514/295000

Abstract:

Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

US Patent:

20040242625, Dec 2, 2004

Filed:

Apr 21, 2004

Appl. No.:

10/830255

Inventors:

Raja Achari - Millington NJ, US
Shamim Ahmed - Central Islip NY, US
Charanjit Behl - Hauppauge NY, US
Jorge deMeireles - Syosset NY, US
Vincent Romeo - Massapequa Park NY, US
Anthony Sileno - Brookhaven Hamlet NY, US

Assignee:

Nastech Pharmaceutical Company, Inc.

International Classification:

A61K031/473

US Classification:

514/295000

Abstract:

Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.

US Patent:

20040242626, Dec 2, 2004

Filed:

Apr 21, 2004

Appl. No.:

10/830309

Inventors:

Raja Achari - Millington NJ, US
Shamim Ahmed - Central Islip NY, US
Charanjit Behl - Hauppauge NY, US
Jorge deMeireles - Syosset NY, US
Vincent Romeo - Massapequa Park NY, US
Anthony Sileno - Brookhaven Hamlet NY, US

Assignee:

Nastech Pharmaceutical Company, Inc.

International Classification:

A61K031/473

US Classification:

514/295000

Abstract:

Intranasal delivery methods and compositions for the delivery of dopamine receptor agonists are provided which are effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal. Nasally administered compositions for treating male erectile dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.